Table of Contents
Conference Papers in Medicine
Volume 2013, Article ID 583175, 5 pages
http://dx.doi.org/10.1155/2013/583175
Conference Paper

Small Changes in Cardiac Troponin Levels Are Common in Patients with Myocardial Infarction: Diagnostic Implications

Department of Clinical Chemistry and Transfusion Medicine, Bruna stråket 16, Sahlgrenska Academy at The University of Gothenburg, 413 45 Gothenburg, Sweden

Received 15 January 2013; Accepted 1 April 2013

Academic Editors: A. Bellou, E. Giannitsis, C. Hamm, M. Möckel, and J. Searle

This Conference Paper is based on a presentation given by O. Hammarsten at “Clinical Decisions in Acute Patients: ACS–POCT–Hypertension and Biomarkers” held from 19 October 2012 to 20 October 2012 in Berlin, Germany.

Copyright © 2013 O. Hammarsten. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Thygesen, J. Mair, E. Giannitsis et al., “How to use high-sensitivity cardiac troponins in acute cardiac care,” European Heart Journal, vol. 33, no. 18, pp. 2252–2257, 2012. View at Publisher · View at Google Scholar
  2. K. Thygesen, J. S. Alpert, A. S. Jaffe et al., “Third universal definition of myocardial infarction,” Circulation, vol. 126, pp. 2020–2035, 2012. View at Publisher · View at Google Scholar
  3. K. Thygesen, J. Mair, H. Katus et al., “Recommendations for the use of cardiac troponin measurement in acute cardiac care,” European Heart Journal, vol. 31, no. 18, pp. 2197–2204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. O. Hammarsten, M. L. Fu, R. Sigurjonsdottir et al., “Troponin t percentiles from a random population sample, emergency room patients and patients with myocardial infarction,” Clinical Chemistry, vol. 58, no. 3, pp. 628–637, 2012. View at Publisher · View at Google Scholar
  5. M. Reiter, R. Twerenbold, T. Reichlin et al., “Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays,” European Heart Journal, vol. 32, no. 11, pp. 1379–1389, 2011. View at Publisher · View at Google Scholar
  6. P. G. Steg, S. K. James, D. Atar et al., “Esc guidelines for the management of acute myocardial infarction in patients presenting with st-segment elevation,” European Heart Journal, vol. 33, no. 20, pp. 2569–2619, 2012. View at Publisher · View at Google Scholar
  7. H. A. Katus, A. Remppis, T. Scheffold, K. W. Diederich, and W. Kuebler, “Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction,” American Journal of Cardiology, vol. 67, no. 16, pp. 1360–1367, 1991. View at Publisher · View at Google Scholar · View at Scopus
  8. A. H. B. Wu, A. S. Jaffe, F. S. Apple et al., “National academy of clinical biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure,” Clinical Chemistry, vol. 53, no. 12, pp. 2086–2096, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. A. M. Nordenskjold, H. Ahlstrom, K. M. Eggers et al., “Short- and long-term individual variation in cardiac troponin in patients with stable coronary artery disease,” Clinical Chemistry, vol. 59, no. 2, pp. 401–409, 2013. View at Publisher · View at Google Scholar
  10. A. H. B. Wu, A. L. Quynh, J. Todd, J. Moecks, and F. Wians, “Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice,” Clinical Chemistry, vol. 55, no. 1, pp. 52–58, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. V. C. Vasile, A. K. Saenger, J. M. Kroning, and A. S. Jaffe, “Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay,” Clinical Chemistry, vol. 56, no. 7, pp. 1086–1090, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. V. Scharnhorst, K. Krasznai, M. van 't Veer, and R. H. Michels, “Variation of cardiac troponin i and t measured with sensitive assays in emergency department patients with noncardiac chest pain,” Clinical Chemistry, vol. 58, no. 8, pp. 1208–1214, 2012. View at Publisher · View at Google Scholar
  13. T. Reichlin, A. Irfan, R. Twerenbold et al., “Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction,” Circulation, vol. 124, no. 2, pp. 136–145, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Mueller, M. Biener, M. Vafaie et al., “Absolute and relative kinetic changes of high-sensitivity cardiac troponin t in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome,” Clinical Chemistry, vol. 58, no. 1, pp. 209–218, 2012. View at Publisher · View at Google Scholar
  15. T. Reichlin, C. Schindler, B. Drexler et al., “One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin t,” Archives of Internal Medicine, vol. 172, no. 16, pp. 1211–1218, 2012. View at Publisher · View at Google Scholar
  16. S. J. Aldous, C. M. Florkowski, I. G. Crozier et al., “Comparison of high sensitivity and contemporary troponin assays for the early detection of acute myocardial infarction in the emergency department,” Annals of Clinical Biochemistry, vol. 48, no. 3, pp. 241–248, 2011. View at Publisher · View at Google Scholar
  17. K. M. Eggers, A. S. Jaffe, P. Venge, and B. Lindahl, “Clinical implications of the change of cardiac troponin I levels in patients with acute chest pain-an evaluation with respect to the Universal Definition of Myocardial Infarction,” Clinica Chimica Acta, vol. 412, no. 1-2, pp. 91–97, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. S. J. Aldous, A. M. Richards, L. Cullen, and M. P. Than, “Early dynamic change in high-sensitivity cardiac troponin T in the investigation of acute myocardial infarction,” Clinical Chemistry, vol. 57, no. 8, pp. 1154–1160, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. F. S. Apple, L. A. Pearce, S. W. Smith, J. M. Kaczmarek, and M. M. Murakami, “Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events,” Clinical Chemistry, vol. 55, no. 5, pp. 930–937, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Keller, T. Zeller, F. Ojeda et al., “Serial changes in highly sensitive troponin i assay and early diagnosis of myocardial infarction,” Journal of the American Medical Association, vol. 306, no. 24, pp. 2684–2693, 2011. View at Publisher · View at Google Scholar
  21. S. Y. Choi and G. S. Mintz, “What have we learned about plaque rupture in acute coronary syndromes?” Current Cardiology Reports, vol. 12, no. 4, pp. 338–343, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Z. H. Rittersma, A. C. Van Der Wal, K. T. Koch et al., “Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis: a pathological thrombectomy study in primary percutaneous coronary intervention,” Circulation, vol. 111, no. 9, pp. 1160–1165, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. A. P. Burke, F. D. Kolodgie, A. Farb et al., “Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression,” Circulation, vol. 103, no. 7, pp. 934–940, 2001. View at Google Scholar · View at Scopus
  24. A. de Torbal, E. Boersma, J. A. Kors et al., “Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study,” European Heart Journal, vol. 27, no. 6, pp. 729–736, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. W. B. Kannel and R. D. Abbott, “Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study,” New England Journal of Medicine, vol. 311, no. 18, pp. 1144–1147, 1984. View at Google Scholar · View at Scopus
  26. D. D. Gutterman, “Silent myocardial ischemia,” Circulation Journal, vol. 73, no. 5, pp. 785–797, 2009. View at Publisher · View at Google Scholar · View at Scopus